The long-term goal of the proposed studies is to understand the molecular mechanisms that mediate allelic exclusion at the T cell receptor (TCR) b locus. Allelic exclusion ensures that individual lymphocytes express a unique antigen receptor and therefore is essential for the clonal activation of lymphocytes during the immune response. Evidence suggests that allelic exclusion is controlled in part through changes in chromatin structure that block the accessibility of substrate gene segments. To identify the underlying cis-regulatory elements, eleven Dnase 1 hypersensitive sites have been identified in a contiguous 95 kb region, starting 20 kb upstream of Db1 and ending 50 kb downstream of Vb14, in DN and DP thymocytes. This proposal aims to systematically test and characterize these putative cis- regulatory elements and their associated factors in allelic exclusion. (1) The role of the two major induced sites in allelic exclusion will be determined by targeted deletion of the sites individually from the endogenous locus. (2) The role of all the identified sites in allelic exclusion will be explored using recombination substrates. The two major induced sites will be deleted simultaneously and the effect of the deletion will be determined in ES cell-derived thymocytes and mature T cells. The remaining nine sites will also be analyzed using recombination substrates by deletion simultaneously and in combinations with the induced sites. Critical sequence motifs within identified sites will be determined by mutations. (3) Trans-acting factors that associate with this identified cis-regulatory elements will be characterized and identified by electrophoretic mobility shift assays and molecular cloning. (4) The presence of additional cis-regulatory elements in the remaining 300 kb region from the endogenous locus and targeted insertion of a Vb13 gene segment upstream of D-b segments. Disregulation of allelic exclusion may block lymphocyte development and/or produce lymphocytes that express more than one type of antigen receptor per cell. An understanding of the control of allelic exclusion at the molecular level may help to elucidate mechanisms that underlie immunodeficiencies and autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI040146-05S1
Application #
6447278
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Prasad, Shiv A
Project Start
1997-04-01
Project End
2002-03-31
Budget Start
2001-05-01
Budget End
2002-03-31
Support Year
5
Fiscal Year
2001
Total Cost
$54,989
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Roper, Jatin; Tammela, Tuomas; Cetinbas, Naniye Malli et al. (2017) In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol 35:569-576
Mahajan, Vinay S; Drake, Adam; Chen, Jianzhu (2009) Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection? Trends Immunol 30:1-7
Leng, Qibin; Nie, Yuchun; Zou, Yongrui et al. (2008) Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development. BMC Immunol 9:51
Palmer, Megan J; Mahajan, Vinay S; Trajman, Lily C et al. (2008) Interleukin-7 receptor signaling network: an integrated systems perspective. Cell Mol Immunol 5:79-89
Bai, Ailin; Hu, Hui; Yeung, Mandy et al. (2007) Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol 178:7632-9
Leng, Qibin; Ge, Qing; Nguyen, Tam et al. (2007) Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes. Proc Natl Acad Sci U S A 104:5038-43
Ge, Qing; Holler, Phillip D; Mahajan, Vinay S et al. (2006) Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms. Proc Natl Acad Sci U S A 103:1822-7
Ge, Qing; Eisen, Herman N; Chen, Jianzhu (2004) Use of siRNAs to prevent and treat influenza virus infection. Virus Res 102:37-42
Ryu, Chun Jeih; Haines, Brian B; Lee, Hye Ran et al. (2004) The T-cell receptor beta variable gene promoter is required for efficient V beta rearrangement but not allelic exclusion. Mol Cell Biol 24:7015-23
Ge, Qing; McManus, Michael T; Nguyen, Tam et al. (2003) RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci U S A 100:2718-23

Showing the most recent 10 out of 20 publications